COMPARISON OF EUROPEAN AND USA GUIDELINES FOR PREVENTION OF CORONARY-HEART-DISEASE

被引:10
|
作者
STEIN, Y
机构
[1] Lipid Research Laboratory, Department of Medicine, Hadassah University Hospital, Jerusalem
关键词
HYPERLIPIDEMIA; ATHEROSCLEROSIS; HDL; LDL; RISK FACTORS;
D O I
10.1016/0021-9150(94)05376-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper deals with the comparison of European and American guidelines for prevention of CHD, screening and management of hyperlipidemia. The revised EAS guidelines consist of 4 chapters: the scientific basis of CHD prevention; strategies for prevention of CHD; setting up a primary care system for CHD prevention, and the fourth focuses on clinical management with healthy diet, lifestyle and drug treatment of risk factors for CHD. The EAS guidelines emphasize that therapeutic decisions are based on the assessment of the global risk of CHD. In both EAS and American guidelines, optimal total plasma cholesterol and triglyceride target values recommended are < 200 mg/dl for both parameters. Both guidelines state that the initial approach to the treatment of hyperlipidemia should involve diet, increased physical activity, and weight reduction. If target levels are not achieved, the physician should determine whether drug therapy is appropriate. Conservative measures (diet and exercise) are recommended in particular for premenopausal women, elderly subjects and adolescents. There is complete agreement on the importance of secondary prevention of CHD.
引用
收藏
页码:S41 / S44
页数:4
相关论文
共 50 条
  • [31] The role of hydrogen in the prevention and treatment of coronary atherosclerotic heart disease
    Chen, Yunxi
    Wei, Youzhen
    Tang, Wenjie
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 972
  • [32] Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care
    Brotons, Carlos
    Maria Lobos, Jose
    Angel Royo-Bordonada, Miguel
    Maiques, Antonio
    de Santiago, Ana
    Castellanos, Angel
    Diaz, Santiago
    Carlos Obaya, Juan
    Pedro-Botet, Juan
    Moral, Irene
    Lizarbe, Vicenta
    Moreno, Rosa
    Perez, Antonio
    Cordero, Alberto
    Fornes-Ubeda, Francisco
    Serrano-Saiz, Benilde
    Camafort-Babkowski, Miguel
    Elosua, Roberto
    Sans, Susana
    de Pablo, Carmen
    Gil-Nunez, Antonio
    de Alvaro-Moreno, Fernando
    Armario, Pedro
    Cortes Rico, Olga
    Villar, Fernando
    Lizcano, Angel
    BMC FAMILY PRACTICE, 2013, 14
  • [33] RISK ASSESSMENT TOOL IN CARDIOVASCULAR DISEASE: A CRITICAL APPRAISAL OF CORONARY HEART DISEASE GUIDELINES
    Sun Xiuting
    Zhuang, Xiaodong
    Zhou, Huimin
    Liao, Xinxue
    JOURNAL OF HYPERTENSION, 2018, 36 : E116 - E116
  • [34] Comments on the new guidelines (2012) of the European Society of Cardiology on cardiovascular disease prevention
    Schuler, G. C.
    Koenig, W.
    Adams, V.
    Gohlke, H.
    KARDIOLOGE, 2013, 7 (04): : 251 - 260
  • [35] Atorvastatin: Lipid lowering activity, pleiotropic properties and efficacy in prevention of atherosclerosis and coronary heart disease
    Bubnova, MG
    KARDIOLOGIYA, 2004, 44 (08) : 96 - 104
  • [36] Executive Summary of the Guidelines on Stable Coronary Disease
    Machado Cesar, Luiz Antonio
    Mansur, Antonio de Padua
    Monteiro Ferreira, Joao Fernando
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 105 (04) : 328 - 338
  • [37] CORONARY HEART-DISEASE RISK-FACTORS IN HANSEN DISEASE SUFFERERS
    DIAMANTOPOULOS, EJ
    ANTHOPOULOS, LP
    MOULOPOULOS, SD
    CLINICAL CARDIOLOGY, 1992, 15 (06) : 436 - 440
  • [38] The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women
    Tziomalos, Konstantinos
    Kakafika, Anna I.
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (10) : 1054 - 1062
  • [39] Nutritional factors in the prevention and management of coronary artery disease and heart failure
    Das, Undurti N.
    NUTRITION, 2015, 31 (02) : 283 - 291
  • [40] Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
    Bubnova, M. G.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (08): : 97 - 107